PlainRecalls
FDA Drug Critical Class I Terminated

Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0105-04.

Reported: February 23, 2022 Initiated: February 3, 2022 #D-0634-2022

Product Description

Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0105-04.

Reason for Recall

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A

Details

Recalling Firm
STAQ Pharma, Inc.
Units Affected
n/a
Distribution
CO, OH, and TX.
Location
Denver, CO

Frequently Asked Questions

What product was recalled?
Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0105-04.. Recalled by STAQ Pharma, Inc.. Units affected: n/a.
Why was this product recalled?
Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A
Which agency issued this recall?
This recall was issued by the FDA Drug on February 23, 2022. Severity: Critical. Recall number: D-0634-2022.